LifeScan glucose meter recall
This article was originally published in The Gray Sheet
Executive Summary
Users of Johnson & Johnson's OneTouch Ultra, OneTouch FastTake and InDuo need not return the blood glucose monitors despite a Class I recall affecting the devices, FDA clarifies in a FDL-1public message on its website June 13. The monitors permit users to "accidentally change the unit of measure" by dropping the instrument or subjecting it to similar trauma. When J&J/LifeScan became aware of the problem earlier this year, it suspended shipments and notified users. "FDA believes that most patients are capable of understanding and following" the firm's instructions, the agency states, noting that LifeScan now offers alternative devices to curb test misinterpretation. LifeScan reps met with CDRH Director Dan Schultz and Office of In Vitro Diagnostic Devices Evaluation & Safety officials June 3...
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.